Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGLV6-57 | P01721 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30228372 | 1.00 | IGLV6-57 (0.45) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30228341 | 1.00 | IGLV6-57 (0.45) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30227929 | 0.90 | IGLV6-57 (0.45) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30228311 | 0.90 | IGLV6-57 (0.45) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30228142 | 0.90 | IGLV6-57 (0.45) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30227948 | 0.83 | IGLV6-57 (0.51) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30228295 | 0.81 | IGLV6-57 (0.49) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL30228185 | 0.78 | IGLV6-57 (0.51) | IGLV6-57ALDH1A1HPGDGLACYP3A4 | |
| SCHEMBL31710449 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDGLAHSD17B10L3MBTL1 | |
| SCHEMBL30228074 | 0.78 | ALDH1A1 (0.48) | ALDH1A1HPGDGLAHSD17B10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326732-A1 | CHROMEN-2-ONE MODULATORS OF POLRMT | PRETZEL THERAPEUTICS, INC. (US) | 2025-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326732-A1 | CHROMEN-2-ONE MODULATORS OF POLRMT | POLRMT, TFAM, POLM | IGLV6-57 4814/4885ALDH1A1 3178/4885HPGD 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.